Sarepta Therapeutics (SRPT) Shares Make Strong Move Off Session Lows
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sarepta Therapeutics (SRPT) Exondys 51 requires "review of drug and site of care required" at Aetna
- Netflix (NFLX) January 132.50 straddle priced for movement of 9.8% into Q4
- Stocks with increasing put volume on January 16